Constellation Brands FY2026 comparable EPS $11.82, down 14%; withdraws FY2028 outlook

CONSTELLATION BRANDS, INC.

FY2026 net sales $9.139B, down 4% comparable; comparable EPS $11.82, down 14% YoY.
Q4 net sales $1.92B, flat comparable; Q4 comparable EPS $1.90, down 28% YoY.
Returned over $1.6B to shareholders including $900M+ in share repurchases during FY2026.
Declares quarterly dividend $1.03 per Class A share, $0.93 per Class 1 convertible, payable May 14.
Withdraws FY2028 outlook and issues updated FY2027 guidance (specific numbers not included in this summary).

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CONSTELLATION BRANDS, INC. reported Fourth quarter ended February 28, 2026 results: revenue $1,920 million, net income $202 million, EPS $1.16.

Period: Fourth quarter ended February 28, 2026
Revenue: $1,920 million
Net income: $202 million
EPS: $1.16
Result: reported results

Exact text from the filing

Fourth Quarter Fiscal 2026 Financial Highlights (1) Reported $1,920 $1,920 $442 $202 $434 $1.16

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CONSTELLATION BRANDS, INC. reported Fiscal year ended February 28, 2026 results: revenue $9,139 million, net income $1,687 million, EPS $9.61.

Period: Fiscal year ended February 28, 2026
Revenue: $9,139 million
Net income: $1,687 million
EPS: $9.61
Result: reported results

Exact text from the filing

Fiscal 2026 Financial Highlights (1) | In millions, except per share data Reported $9,139 $9,139 $2,721 $1,687 $2,730 $9.61

View on SEC.gov

1349 earnings releases filed in the last 30 days. Browse all earnings releases →

CONSTELLATION BRANDS, INC. filing history →

Source: SEC EDGAR

accession 0000016918-26-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.